IMSAInternational Medical Sciences Academy

JIMSA › Vol 35 No 2 · April–June 2022

Case Series · pages 159–166

Diverse Presentation of Mucormycosis: A Post COVID Catastrophe

A Case Series - Pooja Das, Poonam Kumar Saidha, Garima Singal, Vikas Kakkar, Mithun Abraham

Cite this article

A Case Series - Pooja Das, Poonam Kumar Saidha, Garima Singal, Vikas Kakkar, Mithun Abraham. Diverse Presentation of Mucormycosis: A Post COVID Catastrophe. J Int Med Sci Acad. 2022;35(2):159–166.

Opening of the article

The corona virus disease-19 (COVID-19) produced by SARS-CoV-2 has resulted in a wide spectrum of illness ranging from mild to lifethreatening conditions thus enhancing the incidence of opportunistic infections among individuals harbouring comorbidities. Mucormycosis is a dreadful angio-invasive opportunistic infection produced by zygomycetes fungus in an immunocompromised host. The clinical manifestations of mucormycosis include rhino-orbital-cerebral (ROC), pulmonary, cutaneous, gastrointestinal, with ROC accountin g for around 40% of cases. Diabetes, neutropenia, iron overload, cancer, and organ transplant are all major culprits.

Published April–June 2022 · Free to read